NESINA

This brand name is authorized in Australia, Brazil, Canada, Hong Kong, Japan, Singapore, United States

Active ingredients

The drug NESINA contains one active pharmaceutical ingredient (API):

1 Alogliptin UNII EEN99869SC - ALOGLIPTIN BENZOATE

Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high. Read about Alogliptin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NESINA Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BH04		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2933J, 2944Y, 2986E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501114030021802, 501114030022102, 501114030022302, 501114030022402
Country: CA	Health Products and Food Branch	Identifier(s): 02417189, 02417197, 02417200
Country: HK	Department of Health Drug Office	Identifier(s): 63496, 63497, 63498
Country: JP	医薬品医療機器総合機構	Identifier(s): 3969012F1025, 3969012F2021, 3969012F3028
Country: SG	Health Sciences Authority	Identifier(s): 14812P, 14813P, 14814P, 14842P, 14843P
Country: US	FDA, National Drug Code	Identifier(s): 64764-125, 64764-250, 64764-625